Alder Biopharmaceuticals Inc (NASDAQ:ALDR) had its Hold rating reiterated by Cantor Fitzgerald with a $14.00 price target

Analyst Ratings For Alder Biopharmaceuticals Inc (NASDAQ:ALDR)

Story continues below

Today, Cantor Fitzgerald reiterated its Hold rating on Alder Biopharmaceuticals Inc (NASDAQ:ALDR) with a price target of $14.00.

There are 8 Buy Ratings, 4 Hold Ratings, 1 Sell Ratings, no Strong Buy Ratings on the stock.

The current consensus rating on Alder Biopharmaceuticals Inc (NASDAQ:ALDR) is Buy with a consensus target price of $21.4545 per share, a potential 53.47% upside.

Some recent analyst ratings include

  • 2/26/2019-Alder Biopharmaceuticals Inc (NASDAQ:ALDR) had its Hold rating reiterated by Cantor Fitzgerald with a $14.00 price target
  • 12/12/2018-Alder Biopharmaceuticals Inc (NASDAQ:ALDR) had its Hold rating reiterated by Mizuho with a $15.00 price target
  • 11/6/2018-Alder Biopharmaceuticals Inc (NASDAQ:ALDR) has coverage initiated with a Outperform rating
  • 9/10/2018-Alder Biopharmaceuticals Inc (NASDAQ:ALDR) has coverage initiated with a Underweight ➝ Underweight rating and $19.00 price target
  • On 12/3/2018 Jeffrey T L Smith, Insider, sold 5,044 with an average share price of $13.84 per share and the total transaction amounting to $69,808.96.
  • On 11/1/2018 Jeffrey T L Smith, Director, sold 5,040 with an average share price of $13.42 per share and the total transaction amounting to $67,636.80.
  • On 11/1/2018 John A Latham, Insider, sold 25,002 with an average share price of $13.42 per share and the total transaction amounting to $335,526.84.
  • On 10/1/2018 Jeffrey T L Smith, Director, sold 5,040 with an average share price of $15.54 per share and the total transaction amounting to $78,321.60.
  • On 10/1/2018 John A Latham, Insider, sold 24,999 with an average share price of $15.44 per share and the total transaction amounting to $385,984.56.
  • On 9/4/2018 Jeffrey T L Smith, Director, sold 5,040 with an average share price of $18.00 per share and the total transaction amounting to $90,720.00.
  • On 9/4/2018 John A Latham, Insider, sold 24,999 with an average share price of $17.99 per share and the total transaction amounting to $449,732.01.

Recent Trading Activity for Alder Biopharmaceuticals Inc (NASDAQ:ALDR)
Shares of Alder Biopharmaceuticals Inc closed the previous trading session at 14.12 −0.59 3.98% with 14.05 shares trading hands.

An ad to help with our costs